← Leaderboards
Meenakshi Bewtra
University Of Pennsylvania
$1,512,908
Attributed
$3,012,904
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $775K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$2,249,994 · 1
NIH$762,910 · 1
By mechanism
U01$2,249,994 · 1
K08$762,910 · 1
Top collaborators
- Michael D Kappelman3 shared
- Siddharth Singh3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Youhai H Chen$26,569,423
- James D Lewis$18,867,749
- Laura J Balcer$8,319,996
- Gary D. Wu$21,157,114
- Honghong Sun$805,000
Others in their field
Top investigators on “Admission Activity”
- Abhik Das · Research Triangle Institute$33,283,365
- Boyd Taylor Thompson · Massachusetts General Hospital$28,973,793
- Lawrence F Brass · University Of Pennsylvania$27,529,158
- Daniel Woo · University Of Cincinnati$24,370,216
- David Alan Schoenfeld · Massachusetts General Hospital$23,673,021
- Paul Warren Sternberg · California Institute Of Technology$19,444,783
Research focus
Admission ActivityAbdominal AbscessAffectAlgorithmsAnalogAdverse EventAnusBaseBiological Response Modifier TherapyCalcineurin InhibitorCessation Of LifeChronicAnti-Tumor Necrosis Factor TherapyColectomyColonComorbidityComplicationConsultCounselingCox Proportional Hazards ModelsDatabasesDecision MakingDiagnosisDisorder Control
Grant awards (8)
RFA-DP-23-002, Improving Outcomes and Reducing Disparities for Patients with Inflammatory Bowel Disease through Epidemiology, Enhanced Disease Management, Dissemination, and Education$774,997
U01 · FY2025 · DP
RFA-DP-23-002, Improving Outcomes and Reducing Disparities for Patients with Inflammatory Bowel Disease through Epidemiology, Enhanced Disease Management, Dissemination, and Education$774,997
U01 · FY2024 · DP
RFA-DP-23-002, Improving Outcomes and Reducing Disparities for Patients with Inflammatory Bowel Disease through Epidemiology, Enhanced Disease Management, Dissemination, and Education$700,000
U01 · FY2023 · DP
Risk and Risk Preferences for Surgery and Medical Therapy in Ulcerative Colitis$152,582
K08 · FY2013 · DK · contact PI
Risk and Risk Preferences for Surgery and Medical Therapy in Ulcerative Colitis$152,582
K08 · FY2012 · DK · contact PI
Risk and Risk Preferences for Surgery and Medical Therapy in Ulcerative Colitis$152,582
K08 · FY2011 · DK · contact PI
Risk and Risk Preferences for Surgery and Medical Therapy in Ulcerative Colitis$152,582
K08 · FY2010 · DK · contact PI
Risk and Risk Preferences for Surgery and Medical Therapy in Ulcerative Colitis$152,582
K08 · FY2009 · DK · contact PI